5-Bromo-1-(phenylsulfonyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine displays remarkable efficacy in selectively targeting drug-resistant cell lines and impeding their proliferation, thus making it a potential candidate for combating cancer and autoimmune disorders. Its multifaceted nature grants significant prospects in the advancement of novel therapeutic interventions.
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy